“…Among the risk factors, immune system activation/disruption has recently been considered a critical initial step in the pathogenesis of PRES and plays a pivotal role in the development of the disease ( 17 , 18 ). Immunosuppressant or cytotoxic drugs, such as cyclosporin A, tacrolimus/FK-506, methotrexate, sirolimus, lenvatinib, bevacizumab, carboplatin, and paclitaxel, are also significant predisposing factors ( 5 , 12 , 19 - 22 ).…”